Shrinkage of pegylated and non-pegylated liposomes in serum

Colloids and Surfaces B: Biointerfaces

Volumn 114, Issue , 2014, Pages 294-300

  Wolfram, Joy ^a,b   Suri, Krishna ^b   Yang, Yong ^b   Shen, Jianliang ^b,c   Celia, Christian ^b,d   Fresta, Massimo ^e   Zhao, Yuliang ^a,f   Shen, Haifa ^b,g   Ferrari, Mauro ^b,g  

^a NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c SUN YAT SEN UNIVERSITY   (China)

^d UNIVERSITY OF CHIETI   (Italy)

^e UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^f INSTITUTE OF HIGH ENERGY PHYSICS   (China)

^g WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Dynamic light scattering; Liposomes; Polydispersity index; Serum; Size; Zeta potential

Indexed keywords

BODY FLUIDS; DRUG DELIVERY; DYNAMIC LIGHT SCATTERING; PROTEINS; ZETA POTENTIAL;

EFFICIENT DRUG DELIVERY; NANO-DELIVERY SYSTEMS; PHOSPHATIDYLCHOLINE; POLYDISPERSITY INDICES; PROTEIN CORONAS; SERUM; SERUM PROTEINS; SIZE;

LIPOSOMES;

LIPOSOME; MACROGOL; NANOPARTICLE; NON PEGYLATED LIPOSOME; PEGYLATED LIPOSOME; PHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG;

ARTICLE; DRUG DELIVERY SYSTEM; HOMOGENATE; OSMOSIS; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ZETA POTENTIAL;

DYNAMIC LIGHT SCATTERING; LIPOSOMES; POLYDISPERSITY INDEX; SERUM; SIZE; ZETA POTENTIAL;

BUFFERS; HUMANS; LIPOSOMES; NANOSPHERES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POROSITY; SERUM; SILICON DIOXIDE; STATIC ELECTRICITY; TEMPERATURE; TIME FACTORS; WATER;

EID: 84887345045     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.10.009     Document Type: Article

References (27)

1. Wagner V., Dullaart A., Bock A.-K., Zweck A. The emerging nanomedicine landscape. Nat. Biotechnol. 2006, 24:1211-1217.
2. Chang H.-I., Yeh M.-K. Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int. J. Nanomed. 2012, 7:49-60.
3. Koudelka S., Turánek J. Liposomal paclitaxel formulations. J. Controlled Release 2012, 163:322-334.
4. Zhang L., Gu F.X., Chan J.M., Wang A.Z., Langer R.S., Farokhzad O.C. Nanoparticles in medicine: therapeutic applications and developments. Clin. Pharmacol. Ther. 2008, 83:761-769.
5. Allen T.M., Cullis P.R. Liposomal drug delivery systems: from concept to clinical applications. Adv. Drug Deliv. Rev. 2013, 65:36-48.
6. Pasut G., Veronese F.M. State of the art in PEGylation: the great versatility achieved after forty years of research. J. Control Release. 2012, 161:461-472.
7. Immordino M.L., Dosio F., Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int. J. Nanomed. 2006, 1:297-315.
8. Sen K., Mandal M. Second generation liposomal cancer therapeutics: transition from laboratory to clinic. Int. J. Pharm. 2013, 448:28-43.
9. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 2005, 5:161-171.
10. Hamad I., Al-Hanbali O., Hunter A.C., Rutt K.J., Andresen T.L., Moghimi S.M. Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering. ACS Nano 2010, 4:6629-6638.
11. Kim H.R., Andrieux K., Delomenie C., Chacun H., Appel M., Desmaële D., et al. Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip system. Electrophoresis 2007, 28:2252-2261.
12. Gaspar R. Nanoparticles pushed off target with proteins. Nat. Nanotechnol. 2013, 8:79-80.
13. Lundqvist M., Stigler J., Elia G., Lynch I., Cedervall T., Dawson K.A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Nat. Acad. Sci. USA 2008, 105:14265-14270.
14. Mahon E., Salvati A., Baldelli Bombelli F., Lynch I., Dawson K.A. Designing the nanoparticle-biomolecule interface for targeting and therapeutic delivery. J. Control Release 2012, 161:164-174.
15. Monopoli M.P., Aberg C., Salvati A., Dawson K.A. Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotechnol. 2012, 7:779-786.
16. Monopoli M.P., Walczyk D., Campbell A., Elia G., Lynch I., Bombelli F.B., et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 2011, 133:2525-2534.
17. Salvati A., Pitek A.S., Monopoli M.P., Prapainop K., Bombelli F.B., Hristov D.R., et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat. Nanotechnol. 2013, 8:137-143.
18. Murphy R.M. Static and dynamic light scattering of biological macromolecules: what can we learn?. Curr. Opin. Biotechnol. 1997, 8:25-30.
19. Pencer J., White G.F., Hallett F.R. Osmotically induced shape changes of large unilamellar vesicles measured by dynamic light scattering. Biophys. J. 2001, 81:2716-2728.
20. Hupfeld S., Moen H.H., Ausbacher D., Haas H., Brandl M. Liposome fractionation and size analysis by asymmetrical flow field-flow fractionation/multi-angle light scattering: influence of ionic strength and osmotic pressure of the carrier liquid. Chem. Phys. Lipids. 2010, 163:141-147.
21. Sabin J., Prieto G., Ruso J.M., Hidalgo-Álvarez R., Sarmiento F. Size and stability of liposomes: A possible role of hydration and osmotic forces. Eur. Phys. J. E. Soft Matter 2006, 20:401-408.
22. Unsworth L.D., Sheardown H., Brash J.L. Protein resistance of surfaces prepared by sorption of end-thiolated poly(ethylene glycol) to gold: effect of surface chain density. Langmuir 2005, 21:1036-1041.
23. Wei J., Ravn D.B., Gram L., Kingshott P. Stainless steel modified with poly(ethylene glycol) can prevent protein adsorption but not bacterial adhesion. Colloids Surf. B: Biointerfaces 2003, 32:275-291.
24. Zhang F., Kang E.T., Neoh K.G., Wang P., Tan K.L. Surface modification of stainless steel by grafting of poly(ethylene glycol) for reduction in protein adsorption. Biomaterials 2001, 22:1541-1548.
25. Tierney K.J., Block D.E., Longo M.L. Elasticity and phase behavior of DPPC membrane modulated by cholesterol, ergosterol, and ethanol. Biophys J. 2005, 89:2481-2493.
26. Cabral H., Matsumoto Y., Mizuno K., Chen Q., Murakami M., Kimura M., et al. Accumulation of sub-100nm polymeric micelles in poorly permeable tumours depends on size. Nat. Nanotechnol. 2011, 6:815-823.
27. Soo Choi H., Liu W., Misra P., Tanaka E., Zimmer J.P., Itty Ipe B., et al. Renal clearance of quantum dots. Na.t Biotechnol. 2007, 25:1165-1170.